Microbicides
Microbicides
CROI 2012: Conference Overview Highlights Biomedical HIV Prevention
- Details
- Category: HIV Prevention
- Published on Tuesday, 06 March 2012 00:00
- Written by Liz Highleyman
HIV prevention was the key theme at Monday's opening press overview of the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012), taking place this week in Seattle.
VOICE HIV Prevention Trial Halts Tenofovir Gel Arm
- Details
- Category: HIV Prevention
- Published on Tuesday, 29 November 2011 00:00
- Written by Liz Highleyman
On November 25 the National Institutes of Health (NIH) and the Microbicide Trials Network (MTN) announced the discontinuation of an arm of the VOICE study that was evaluating a tenofovir vaginal microbicide, due to lack of effectiveness in an interim analysis.
Tenofovir Microbicide Gel May Prevent Genital Herpes in Addition to HIV Infection
- Details
- Category: Microbicides
- Published on Tuesday, 25 October 2011 00:00
- Written by NIH
A vaginal gel containing the HIV nucleotide reverse transcriptase inhibitor tenofovir (known as Viread in pill form, also in the Truvada and Atripla coformulations) inhibits replication of herpes simplex virus, researchers reported in the October 4, 2011, issue of Cell Host and Microbes. Tenofovir gel has already been shown to reduce HIV infection by about 40%, and the new findings suggest it may have a dual benefit.
UC781 Rectal Microbicide Appears Safe and Well-Tolerated
- Details
- Category: HIV Prevention
- Published on Tuesday, 15 November 2011 00:00
- Written by Press Release
The investigational rectal microbicide gel UC781 produced no adverse events and study participants said they would be likely to use it if found effective at reducing the risk of HIV infection, according to a study described in the September 28, 2011, edition of PLoS Medicine.
Gene Therapy Microbicide Protects Mice Against HIV
- Details
- Category: Microbicides
- Published on Friday, 20 May 2011 04:03
- Written by Children’s Hospital Boston
CD4 cells engineered to knock out HIV genes or CCR5 co-receptors blocked viral infection in laboratory cells and humanized mice, suggesting they can be used in a vaginal microbicide to prevent sexual transmission of HIV.
More Articles...
- New NRTI Microbicide Looks Promising in Lab
- CROI 2011: Safety and Acceptability of Tenofovir Gel and Tablets for Pre-exposure Prevention
- FDA Grants Fast-track Status for Tenofovir Microbicide Gel for HIV Prevention
- CAPRISA Microbicide Trial Shows Tenofovir Vaginal Gel Reduces HIV Transmission Risk by 39%
Web Design and Development by